Breakthroughs in Chikungunya Research Spell New Hope for Better Treatment and Protection

News   Sep 24, 2012

 
Breakthroughs in Chikungunya Research Spell New Hope for Better Treatment and Protection
 
 
 

RELATED ARTICLES

Using Epigenetic Signatures and Machine Learning to Improve Diagnosis

News

Unique epigenetic signatures for nine neurodevelopmental disorders have been identified, lending to a better method of diagnosis for disorders with much clinical overlap.

READ MORE

Latent HIV Reservoirs Inherently Resistant to Elimination by CD8+ T-cells

News

The latest “kick-and-kill” research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study found that latent HIV reservoirs show resistance to CD8+ T-cells, a type of white blood cell whose primary function is to kill infected cells.

READ MORE

LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target Discovery

News

LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE